Skip to main content

Pouchitis clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for
  • Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch

    Sorry, in progress, not accepting new patients

    The goal of this clinical trial is to learn if mirikizumab works to treat pouch disorders in adults. The main questions it aims to answer are: Does mirikizumab reduce symptoms of pouch disorders Participants will: Take mirikizumab every 4 weeks for one year Visit the clinic once every month for two months and at the end of the study Keep a diary of their symptoms

    Los Angeles, California and other locations

Last updated: